Clinical Trial Update: Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 trial evaluating the combination of NMS-03305293 and temozolomide in adults with recurrent glioblastoma; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Glioma
• Glioblastoma

Drugs mentioned

• NMS-03305293
• Temozolomide (Temozolomide)

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Glioblastoma, Diffuse Glioma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING